To further confirm the existence of the HBx–NF-κB–SHP2 pathway, we obtained 23 pairs of tumor tissues and surrounding non-neoplastic tissues from patients with HBV-associated HCC and analyzed SHP2 expression via Western blot analysis. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.